High growth, ROE and relative strength for NYSE:BMA, growth investors may appreciate this.

Last update: Apr 9, 2024

Groth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if BANCO MACRO SA-ADR (NYSE:BMA) is suited for growth investing. Investors should of course do their own research, but we spotted BANCO MACRO SA-ADR showing up in our CANSLIM growth screen, so it may be worth spending some more time on it.

Some of the canslim metrics of NYSE:BMA highlighted

The recent financial report of BANCO MACRO SA-ADR demonstrates a 2.0K% increase in quarterly earnings compared to the previous quarter. This growth indicates positive momentum in the company's financials and suggests a promising upward trend
The recent q2q revenue growth of 891.0% of BANCO MACRO SA-ADR showcases the company's ability to generate increasing revenue in a short period, reflecting its positive growth trajectory.
BANCO MACRO SA-ADR has experienced 152.0% growth in EPS over a 3-year period, demonstrating its ability to generate sustained and positive earnings momentum.
BANCO MACRO SA-ADR showcases a robust Return on Equity (ROE) of 29.32%, indicating its ability to generate favorable returns for shareholders. This metric underscores the company's efficiency in utilizing its equity capital to generate profits.
BANCO MACRO SA-ADR has exhibited strong Relative Strength(RS) in recent periods, with a current 97.9 rating. This indicates the stock's ability to outperform the broader market and reflects its competitive position. BANCO MACRO SA-ADR shows promising potential for continued price momentum.
With a current Debt-to-Equity ratio at 0.21, BANCO MACRO SA-ADR showcases its disciplined capital structure. The company's prudent management of debt obligations contributes to its financial stability and long-term sustainability.
The ownership composition of BANCO MACRO SA-ADR reflects a balanced investor ecosystem, with institutional shareholders owning 6.79%. This indicates a broader market participation and potential for increased trading liquidity.

Analyzing the Technical Aspects

Every day, ChartMill assigns a Technical Rating to each stock, providing a score ranging from 0 to 10. This rating is determined by evaluating various technical indicators and properties.

Overall BMA gets a technical rating of 10 out of 10. This is due to a consistent performance in both the short and longer term time frames. Also compared to the overall market, BMA is showing a nice and steady performance.

Both the short term and long term trends are positive. This is a very positive sign.
When comparing the yearly performance of all stocks, we notice that BMA is one of the better performing stocks in the market, outperforming 97% of all stocks.
BMA is one of the better performing stocks in the Banks industry, it outperforms 99% of 412 stocks in the same industry.
BMA is currently trading near its 52 week high, which is a good sign. The S&P500 Index however is also trading near new highs, which makes the performance in line with the market.
In the last month BMA has a been trading in the 38.55 - 54.67 range, which is quite wide. It is currently trading near the high of this range.

For an up to date full technical analysis you can check the technical report of BMA

What is the full fundamental picture of NYSE:BMA telling us.

At ChartMill, a crucial aspect of their analysis is the assignment of a Fundamental Rating to each stock. This rating, ranging from 0 to 10, is calculated daily by considering numerous fundamental indicators and properties.

Overall BMA gets a fundamental rating of 3 out of 10. We evaluated BMA against 412 industry peers in the Banks industry. BMA has a bad profitability rating. Also its financial health evaluation is rather negative. BMA is valued quite expensive, but it does show an excellent growth.

For an up to date full fundamental analysis you can check the fundamental report of BMA

More growth stocks can be found in our CANSLIM screen.

Disclaimer

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.